Veracyte, Inc.
USD58.95
-1.24 (-2.07%)
CEO
Marc Stapley
IPO Date
2013-10-29
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$60.42
Prev. Close
$60.19
Day Low
$58.51
Day High
$60.91
52W Low
$22.61
52W High
$60.83
Market Cap
$4.70B
Volume
0.20M
| 125.5 |
| 31 Dec 2023 | FY | 68.7% | -20.6% | -7.1% | -6.7% | 0.01 | 4.66 | -26.9 |
| 31 Dec 2022 | FY | 65.7% | -12.3% | -3.4% | -3.2% | 0.01 | 3.97 | -46.4 |
| 31 Dec 2021 | FY | 66.1% | -34.4% | -6.9% | -6.4% | 0.02 | 3.79 | -37.0 |
| 31 Dec 2020 | FY | 64.7% | -29.7% | -8.3% | -7.6% | 0.03 | 22.39 | -74.6 |
| 31 Dec 2019 | FY | 69.7% | -10.5% | -5.3% | -4.6% | 0.06 | 10.74 | -102.2 |
| 31 Dec 2018 | FY | 64.0% | -25.0% | -28.8% | -19.1% | 0.32 | 7.42 | -20.2 |
| 31 Dec 2017 | FY | 60.8% | -43.1% | -83.3% | -39.4% | 0.68 | 4.48 | -7.1 |
| 31 Dec 2016 | FY | 60.9% | -48.2% | -52.6% | -31.0% | 0.43 | 6.38 | -7.1 |
| 20.3 |
| 30 Sept 2025 | Q3 | 69.2% | 14.5% | 1.5% | 1.4% | 0.03 | 6.23 | 35.3 |
| 30 Jun 2025 | Q2 | 69.0% | -0.8% | -0.1% | -0.1% | 0.04 | 5.43 | -539.3 |
| 31 Mar 2025 | Q1 | 69.5% | 6.2% | 0.6% | 0.5% | 0.04 | 5.10 | 82.1 |
| 31 Dec 2024 | Q4 | 66.4% | 4.3% | 0.4% | 0.4% | 0.04 | 4.73 | 150.3 |
| 30 Sept 2024 | Q3 | 68.2% | 13.1% | 1.3% | 1.2% | 0.02 | 5.08 | 43.2 |
| 30 Jun 2024 | Q2 | 68.1% | 5.0% | 0.5% | 0.5% | 0.02 | 4.44 | 71.2 |
| 31 Mar 2024 | Q1 | 64.5% | -1.9% | -0.2% | -0.2% | 0.01 | 5.00 | -217.0 |
| 31 Dec 2023 | Q4 | 70.1% | -28.8% | -2.7% | -2.5% | 0.01 | 4.66 | -17.8 |